Clinical Edge Journal Scan

Migraine elevates risk for ischemic stroke in men and women with migraine


 

Key clinical point: Migraine increased the risk for premature ischemic stroke similarly among women and men aged ≤60 years; however, the effect of migraine on the risk for premature myocardial infarction (MI) and hemorrhagic stroke was greater only in women but not in men with migraine.

Major finding: Compared with those without migraine , women (adjusted HR [aHR] 1.21) and men (aHR 1.23; both P < .001) with migraine showed a similar increase in the risk for premature ischemic stroke. However, the risk for premature MI (aHR 1.22; 95% CI 1.14-1.31; P < .001) and hemorrhagic stroke (aHR 1.13; 95% CI 1.02-1.24; P = .014) was significantly higher in women with vs without migraine but not in men.

Study details: This nationwide population-based cohort study included 179,680 women and 40,757 men with migraine.

Disclosures: This study did not receive any specific funding. CH Fuglsang declared owning stock in Novo Nordisk, and M Schmidt declared being supported by the Novo Nordisk Foundation.

Source: Fuglsang CH et al. Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study. PLoS Med. 2023;20(6):e1004238 (Jun 13). Doi: 10.1371/journal.pmed.1004238

Recommended Reading

Galcanezumab safe and effective for chronic migraine and medication overuse headache
Migraine ICYMI
Migraine clusters emerge from machine-learning analysis
Migraine ICYMI
Cannabis RCT shows efficacy, AEs in migraine
Migraine ICYMI
Migraine device expands treatment possibilities
Migraine ICYMI
Can a puff of cool air up the nose stop acute migraine?
Migraine ICYMI
Anti-CGRP monoclonal antibody offers relief from migraine and comorbid depression
Migraine ICYMI
Migraine treatment with rimegepant linked to reduced barbiturate use
Migraine ICYMI
Prodrome treatment with ubrogepant prevents migraines
Migraine ICYMI
What is the proper treatment for posttraumatic headache? Expert debate
Migraine ICYMI
Commentary: Refractory chronic migraine treatment, July 2023
Migraine ICYMI